Chickenpox: Clinical Trials

14 trials for Chickenpox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Chickenpox: new trials by email Literature Review of Chickenpox trials Research Report on Chickenpox

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)
Varicella vaccine+TIV, Varicella vaccine, TIV - Varicella, Influenza Vaccine
Phase 4CompletedSinovac (Dalian) Vaccine Technology Co., Ltd.8992024-09-212025-05-23
Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old
Skyvaricella Injection - Chickenpox
Phase 4CompletedVietnam Military Medical University2012021-04-172023-07-06
A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine - Varicella
Phase 4CompletedSinovac (Dalian) Vaccine Technology Co., Ltd.4502021-04-082022-09-02
Zoster Eye Disease Study
Masked Placebo, Masked Oral Valacyclovir - Herpes Zoster Ophthalmicus
Phase 4CompletedNYU Langone Health5272017-08-232025-03-07
Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
varicella-1, varicella-3, varicella-5 - Varicella
Phase 4CompletedChangchun Keygen Biological Products Co., Ltd.7162014-06-012014-09-01
Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Live Attenuated Varicella Vaccine - Chickenpox
Phase 4CompletedChangchun Keygen Biological Products Co., Ltd.3682013-03-012013-10-16
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
Live Attenuated Varicella Vaccine + Live Attenuated JE Vaccine, Live Attenuated Varicella Vaccine, live attenuated JE vaccine - Japanese Encephalitis, Chickenpox
Phase 4CompletedChangchun Keygen Biological Products Co., Ltd.4972013-03-012014-02-24
Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin
vaccine without gelatin, vaccine with gelatin - Chickenpox, Zoster
Phase 4CompletedBeijing Center for Disease Control and Prevention12002011-01-012012-09-12
The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
VZV vaccination - HIV Infections, Varicella-zoster Virus
Phase 4CompletedThe HIV Netherlands Australia Thailand Research Collaboration602009-06-012020-07-17
Safety of a Second Dose of Biken's Varicella Vaccine
Live Attenuated Varicella Virus Vaccine - Varicella
Phase 4CompletedSanofi Pasteur, a Sanofi Company1222009-01-012013-06-10
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)
VAQTA®, ProQuad - Hepatitis A, Measles
Phase 4CompletedMerck Sharp & Dohme LLC18002007-03-262019-02-04
Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Measles, Mumps, Rubella and Chickenpox (live vaccine) - Mumps, Rubella
Phase 4CompletedGlaxoSmithKline14392005-05-012016-09-21
Safety Study of a Refrigerator-stable Formulation of VARIVAX®
VARIVAX®, M-M-RTM II - Varicella, Measles
Phase 4CompletedMerck Sharp & Dohme LLC5002004-12-012017-03-14
Varicella Vaccination With Pulmicort
budesonide, varicella zoster virus - Asthma
Phase 4CompletedAstraZeneca2502001-10-012009-03-25

Narrower conditions

Measles (3)  ·  Mumps (3)  ·  Rubella (3)  ·  Herpes Zoster (2)  ·  Asthma (1)  ·  Encephalitis, Japanese (1)  ·  HIV Infections (1)  ·  Hepatitis A (1)  ·  Herpes Zoster Ophthalmicus (1)  ·  Influenza, Human (1)

Broader conditions

DNA Virus Infections (14)  ·  Herpesviridae Infections (14)  ·  Infections (14)  ·  Varicella Zoster Virus Infection (14)  ·  Virus Diseases (14)  ·  RNA Virus Infections (6)  ·  Mononegavirales Infections (3)  ·  Morbillivirus Infections (3)  ·  Mouth Diseases (3)  ·  Paramyxoviridae Infections (3)  ·  Parotid Diseases (3)  ·  Parotitis (3)  ·  Rubivirus Infections (3)  ·  Rubulavirus Infections (3)  ·  Salivary Gland Diseases (3)

Interventions

Chickenpox Vaccine (3)  ·  Budesonide (1)  ·  Gelatin (1)  ·  Hepatitis A Vaccines (1)  ·  Vaccines (1)  ·  Vaccines, Attenuated (1)  ·  Valacyclovir (1)  ·  measles, mumps, rubella, varicella vaccine (1)

Sponsors

Changchun Keygen Biological Products Co., Ltd. (3)  ·  Merck Sharp & Dohme LLC (2)  ·  Sinovac (Dalian) Vaccine Technology Co., Ltd. (2)  ·  AstraZeneca (1)  ·  Beijing Center for Disease Control and Prevention (1)  ·  GlaxoSmithKline (1)  ·  NYU Langone Health (1)  ·  Sanofi Pasteur, a Sanofi Company (1)  ·  The HIV Netherlands Australia Thailand Research Collaboration (1)  ·  Vietnam Military Medical University (1)

Countries

China (6)  ·  Argentina (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Poland (1)  ·  Thailand (1)  ·  United States (1)  ·  Vietnam (1)

Top investigators

Huizhen Zheng, Master (2)  ·  Bertill Andersson (1)  ·  Dianmin Kang (1)  ·  Elisabeth Cohen, MD (1)  ·  Nianmin Shi (1)  ·  Pham N Hung, As. Prof. (1)  ·  Zheng Huizhen, Master (1)

Results publications

PMID 19305145, PMID 35090154, PMID 36593652, PMID 38411973, PMID 40048183, PMID 40048191, PMID 42593809, PMID 42635062

NIH funding

U10EY026869 (1)